Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Surg Res ; 253: 115-120, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32353636

RESUMO

BACKGROUND: Pleuropulmonary blastoma (PPB) is the most common primary lung cancer in children. While rare, these tumors are highly aggressive. Tumor recurrence and overall survival are dependent on histologic grade and extent of surgical resection. We sought to examine our institutional experience with PPB to determine the effect of gross total resection (GTR) on recurrence and patient outcomes. MATERIALS AND METHODS: After IRB approval, a retrospective chart review from 1998 to 2018 was performed. Cases were confirmed by histology and Dehner Grade (I to III). Data collection included demographics, treatment, extent of surgical resection, and patient outcomes. RESULTS: Eight patients with nine procedures were identified. Histologically, three cases were type 1, 2 type 2, and four poor prognosis type 3. Three patients received neoadjuvant chemotherapy to facilitate surgical resection. The operative goal was to achieve GTR (>95%), and to this end, three partial lobectomies, five lobectomies, and one pneumonectomy were performed. All nine cases achieved GTR, of which eight had negative microscopic margins. Two patients with type III disease recurred (one locally, one distant) and died. One type 3 patient had a positive microscopic hilar margin not amenable to further resection. The patient recurred (distant) but is in remission. With respect to patient outcomes, the event-free survival was 2.3 y with an overall survival of 3.3 y. CONCLUSIONS: From our experience, GTR of PPB is associated with minimal surgical morbidity and good overall survival. Multi-institutional studies are needed to determine if positive surgical margins affect outcomes given the morbidity of mediastinal dissection.


Assuntos
Neoplasias Pulmonares/terapia , Recidiva Local de Neoplasia/epidemiologia , Pneumonectomia/métodos , Blastoma Pulmonar/terapia , Quimioterapia Adjuvante/métodos , Quimioterapia Adjuvante/estatística & dados numéricos , Pré-Escolar , Intervalo Livre de Doença , Feminino , Humanos , Lactente , Recém-Nascido , Pulmão/patologia , Pulmão/cirurgia , Neoplasias Pulmonares/mortalidade , Neoplasias Pulmonares/patologia , Masculino , Margens de Excisão , Terapia Neoadjuvante/métodos , Terapia Neoadjuvante/estatística & dados numéricos , Gradação de Tumores , Recidiva Local de Neoplasia/prevenção & controle , Pneumonectomia/estatística & dados numéricos , Prognóstico , Blastoma Pulmonar/mortalidade , Blastoma Pulmonar/patologia , Estudos Retrospectivos , Fatores de Tempo
2.
JBJS Case Connect ; 7(4): e79, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29286963

RESUMO

CASE: We report a case of kaposiform hemangioendothelioma (KHE) of the scapula in a 2-year-old boy with motor and sensory abnormalities of the left upper extremity, suggesting brachial plexus involvement. The locally invasive nature prevented resection; sirolimus therapy resulted in improvement of the motor and sensory impairment, as well as decreased tumor size on imaging. CONCLUSION: Osseous infiltration of KHE is known to occur, but its primary presentation in bone without skin involvement is rare and diagnostically challenging. Awareness of rare presentations of KHE, along with accurate histopathologic interpretation, is important to achieve a diagnosis and to differentiate KHE from more common vascular lesions (e.g., infantile hemangioma). Sirolimus therapy is emerging as a promising treatment for unresectable KHE.


Assuntos
Neuropatias do Plexo Braquial/fisiopatologia , Hemangioendotelioma/fisiopatologia , Síndrome de Kasabach-Merritt/fisiopatologia , Sarcoma de Kaposi/fisiopatologia , Plexo Braquial/fisiopatologia , Neuropatias do Plexo Braquial/tratamento farmacológico , Pré-Escolar , Hemangioendotelioma/tratamento farmacológico , Humanos , Imunossupressores/uso terapêutico , Síndrome de Kasabach-Merritt/tratamento farmacológico , Masculino , Amplitude de Movimento Articular , Sarcoma de Kaposi/tratamento farmacológico , Escápula/fisiopatologia , Sirolimo/uso terapêutico , Extremidade Superior/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA